DE
DXCM icon

DV Equities’s DexCom DXCM Stock Holding History

DV Equities’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$36.2K Buy
+546
New +$35.3K 0.01% 422

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

DV Equities's DXCM Position: Q4 2025 in Review

DV Equities opened a new position in DexCom (DXCM) in Q4 2025: 546 shares worth $36.2K. The stake represents 0.01% of the portfolio and ranks #422 among its holdings.

922 funds tracked by Wall St. Rank hold DXCM as of Q4 2025.

  • DV Equities held 546 shares of DexCom worth $36.2K as of Q4 2025.
  • DexCom was a new DV Equities position in Q4 2025.
  • DexCom made up 0.01% of DV Equities's portfolio in Q4 2025, its #422 holding.
  • 922 funds tracked by Wall St. Rank held DexCom as of Q4 2025.

Based on DV Equities's 13F filing for Q4 2025, filed 17 Feb 2026.